Canada Life’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,173
Closed -$449K 2095
2024
Q2
$449K Hold
13,173
﹤0.01% 1696
2024
Q1
$463K Sell
13,173
-3,765
-22% -$126K ﹤0.01% 1704
2023
Q4
$486K Buy
16,938
+2,663
+19% +$63.4K ﹤0.01% 1705
2023
Q3
$327K Sell
14,275
-738
-5% -$38.7K ﹤0.01% 1775
2023
Q2
$867K Buy
15,013
+1,632
+12% +$85.2K ﹤0.01% 1539
2023
Q1
$505K Sell
13,381
-77
-0.6% -$2.84K ﹤0.01% 1702
2022
Q4
$362K Buy
13,458
+6,499
+93% +$178K ﹤0.01% 1784
2022
Q3
$196K Buy
6,959
+6,171
+783% +$172K ﹤0.01% 1875
2022
Q2
$17K Hold
788
﹤0.01% 2298
2022
Q1
$34K Hold
788
﹤0.01% 2254
2021
Q4
$37K Hold
788
﹤0.01% 2258
2021
Q3
$45K Hold
788
﹤0.01% 2263
2021
Q2
$45K Hold
788
﹤0.01% 2306
2021
Q1
$49K Hold
788
﹤0.01% 2302
2020
Q4
$26K Buy
+788
New +$23.3K ﹤0.01% 2497

Other funds holding MORF

Canada Life's MORF Position: Q3 2024 in Review

Canada Life sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 13,173 shares — an estimated $449K sold.

Canada Life first reported a position in MORF in Q4 2020 and held it in 15 quarters. The position peaked at $867K in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Canada Life reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Canada Life sold 13,173 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $449K.
  • Canada Life first reported a position in Morphic Holding, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • Canada Life's Morphic Holding, Inc. Common Stock position peaked at $867K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.